{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T02:08:48Z","timestamp":1792807728318,"version":"4.5.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,10,17]],"date-time":"2022-10-17T00:00:00Z","timestamp":1665964800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,10,17]],"date-time":"2022-10-17T00:00:00Z","timestamp":1665964800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100014588","name":"Sanofi Pasteur","doi-asserted-by":"publisher","award":["E002566548"],"award-info":[{"award-number":["E002566548"]}],"id":[{"id":"10.13039\/100014588","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Global Health"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Vaccination can reduce antibiotic use by decreasing bacterial and viral infections and vaccines are highlighted in the WHO Global Action Plan on Antimicrobial Resistance (AMR) as an infection prevention measure to reduce AMR. Our study aimed to analyze whether WHO Member States have developed AMR national action plans that are aligned with the Global Action Plan regarding objectives on vaccination.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We reviewed 77 out of 90 AMR national action plans available in the WHO library that were written after publication of the Global Action Plan in 2015. Each plan was analyzed using content analysis, with a focus on vaccination and key components as defined by WHO (I. Strategic plan (e.g. goals and objectives), II. Operational plan, III. Monitoring and Evaluation plan).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Vaccination was included in 67 of 77 AMR plans (87%) across all WHO Regions (Africa: <jats:italic>n<\/jats:italic>\u00a0=\u200913\/13, the Eastern Mediterranean: <jats:italic>n<\/jats:italic>\u00a0=\u200915\/16, Europe: <jats:italic>n<\/jats:italic>\u00a0=\u200910\/14, the Americas: <jats:italic>n<\/jats:italic>\u00a0=\u20098\/8, South-East Asia: <jats:italic>n<\/jats:italic>\u00a0=\u20098\/11, and the Western Pacific: <jats:italic>n<\/jats:italic>\u00a0=\u200913\/15). Pneumococcal and influenza vaccination were most frequently highlighted (<jats:italic>n<\/jats:italic>\u00a0=\u200912 and <jats:italic>n<\/jats:italic>\u00a0=\u200911). We found indications that vaccination objectives are more often included in AMR plans from lower income countries, while higher income countries more often include specific vaccines. The key WHO components of national action plans were frequently not covered (I. 47% included, II. 57%, III. 40%). In total, 33 countries (43%) included indicators (e.g. strategic objectives) to capture the role of vaccines against AMR.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>While vaccination to reduce AMR is seen as an important global public health issue by WHO, there appears to be a gap in its adoption in national AMR plans. Country income levels seem to influence the progress, implementation and focus of national action plans, guided by a lack of funding and prioritization in developing countries. To better align the global response to AMR, our review suggests there is a need to update national action plans to include objectives on vaccination with more focus on specific vaccines that impact antibiotic use.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12992-022-00878-6","type":"journal-article","created":{"date-parts":[[2022,10,17]],"date-time":"2022-10-17T09:03:48Z","timestamp":1665997428000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Assessment of the inclusion of vaccination as an intervention to reduce antimicrobial resistance in AMR national action plans: a global review"],"prefix":"10.1186","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6638-9413","authenticated-orcid":false,"given":"Lotte","family":"van Heuvel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saverio","family":"Caini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel L. A.","family":"D\u00fcckers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Paget","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,10,17]]},"reference":[{"key":"878_CR1","volume-title":"Tackling drug-resistant infections globally: final report and recommendations. Review on Antimicrobial Resistance","author":"J O'Neill","year":"2016","unstructured":"O'Neill J. Tackling drug-resistant infections globally: final report and recommendations. Review on Antimicrobial Resistance; 2016."},{"key":"878_CR2","volume-title":"Global Action Plan on Antimicrobial Resistance","author":"World health organization","year":"2015","unstructured":"World health organization. Global Action Plan on Antimicrobial Resistance 2015."},{"key":"878_CR3","volume-title":"Leveraging vaccines to reduce antibiotic use and prevent antimicrobial resistance: an Action Framework","author":"World Health Organization","year":"2020","unstructured":"World Health Organization. Leveraging vaccines to reduce antibiotic use and prevent antimicrobial resistance: an Action Framework. 2020."},{"key":"878_CR4","volume-title":"The value of vaccines in the avoidance of antimicrobial resistance","author":"Chatham House","year":"2017","unstructured":"Chatham House. The value of vaccines in the avoidance of antimicrobial resistance. 2017."},{"key":"878_CR5","volume-title":"The role of vaccination in reducing antimicrobial resistance (AMR)","author":"Vaccines Europe","year":"2016","unstructured":"Vaccines Europe. The role of vaccination in reducing antimicrobial resistance (AMR). 2016."},{"key":"878_CR6","volume-title":"The global response to AMR: momentum, success, and critica gaps","author":"Wellcome","year":"2020","unstructured":"Wellcome. The global response to AMR: momentum, success, and critica gaps. 2020."},{"issue":"6","key":"878_CR7","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1080\/07853890.2020.1782460","volume":"52","author":"TM Doherty","year":"2020","unstructured":"Doherty TM, Hausdorff WP, Kristinsson KG. Effect of vaccination on the use of antimicrobial agents: a systematic literature review. Ann Med. 2020;52(6):283\u201399.","journal-title":"Ann Med"},{"issue":"10","key":"878_CR8","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1016\/j.cmi.2019.06.030","volume":"25","author":"BS Buckley","year":"2019","unstructured":"Buckley BS, Henschke N, Bergman H, Skidmore B, Klemm EJ, Villanueva G, et al. Impact of vaccination on antibiotic usage: a systematic review and meta-analysis. Clin Microbiol Infect. 2019;25(10):1213\u201325.","journal-title":"Clin Microbiol Infect"},{"issue":"5","key":"878_CR9","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1111\/irv.12398","volume":"10","author":"EY Klein","year":"2016","unstructured":"Klein EY, Monteforte B, Gupta A, Jiang W, May L, Hsieh YH, et al. The frequency of influenza and bacterial coinfection: a systematic review and meta-analysis. Influenza Other Respir Viruses. 2016;10(5):394\u2013403.","journal-title":"Influenza Other Respir Viruses"},{"issue":"9","key":"878_CR10","doi-asserted-by":"publisher","first-page":"2142","DOI":"10.1080\/21645515.2018.1476814","volume":"14","author":"KU Jansen","year":"2018","unstructured":"Jansen KU, Anderson AS. The role of vaccines in fighting antimicrobial resistance (AMR). Hum Vaccin Immunother. 2018;14(9):2142\u20139.","journal-title":"Hum Vaccin Immunother"},{"issue":"10325","key":"878_CR11","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/S0140-6736(21)02724-0","volume":"399","author":"Antimicrobial Resistance Collaborators","year":"2022","unstructured":"Antimicrobial Resistance Collaborators. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. Lancet. 2022;399(10325):629\u201355.","journal-title":"Lancet."},{"issue":"9","key":"878_CR12","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1093\/cid\/ciw067","volume":"62","author":"S Tomczyk","year":"2016","unstructured":"Tomczyk S, Lynfield R, Schaffner W, Reingold A, Miller L, Petit S, et al. Prevention of antibiotic-nonsusceptible invasive pneumococcal disease with the 13-valent pneumococcal conjugate vaccine. Clin Infect Dis. 2016;62(9):1119\u201325.","journal-title":"Clin Infect Dis"},{"key":"878_CR13","doi-asserted-by":"crossref","unstructured":"Ozawa S, Chen HH, Rao GG, Eguale T, Stringer A. Value of pneumococcal vaccination in controlling the development of antimicrobial resistance (AMR): case study using DREAMR in Ethiopia. Vaccine. 2021.","DOI":"10.1016\/j.vaccine.2021.04.024"},{"issue":"24","key":"878_CR14","doi-asserted-by":"publisher","first-page":"4073","DOI":"10.1016\/j.vaccine.2010.03.075","volume":"28","author":"HJ Adam","year":"2010","unstructured":"Adam HJ, Richardson SE, Jamieson FB, Rawte P, Low DE, Fisman DN. Changing epidemiology of invasive Haemophilus influenzae in Ontario, Canada: evidence for herd effects and strain replacement due to Hib vaccination. Vaccine. 2010;28(24):4073\u20138.","journal-title":"Vaccine."},{"issue":"6","key":"878_CR15","doi-asserted-by":"publisher","first-page":"2561","DOI":"10.1128\/AAC.49.6.2561-2564.2005","volume":"49","author":"KP Heilmann","year":"2005","unstructured":"Heilmann KP, Rice CL, Miller AL, Miller NJ, Beekmann SE, Pfaller MA, et al. Decreasing prevalence of beta-lactamase production among respiratory tract isolates of Haemophilus influenzae in the United States. Antimicrob Agents Chemother. 2005;49(6):2561\u20134.","journal-title":"Antimicrob Agents Chemother"},{"key":"878_CR16","unstructured":"van Heuvel L, Caini S, D\u00fcckers M, Paget J Influenza Vaccination and Antimicrobial Resistance: Strategic Recommendations NIVEL; 2020."},{"key":"878_CR17","volume-title":"Antimicrobial resistance: draft global action plan on antimicrobial resistance: report by the secretariat.: world health Organization","author":"World health assembly","year":"2015","unstructured":"World health assembly. Antimicrobial resistance: draft global action plan on antimicrobial resistance: report by the secretariat.: world health Organization; 2015."},{"key":"878_CR18","unstructured":"WHO. Monitoring progress on antimicrobial resistance. 2021. Available from: https:\/\/www.who.int\/activities\/monitoring-progress-antimicrobial-resistance."},{"key":"878_CR19","doi-asserted-by":"crossref","unstructured":"Vekemans J, Hasso-Agopsowicz M, Kang G, Hausdorff WP, Fiore A, Tayler E, et al. Leveraging vaccines to reduce antibiotic use and prevent antimicrobial resistance: a WHO action framework. Clin Infect Dis. 2021.","DOI":"10.1093\/cid\/ciab062"},{"key":"878_CR20","unstructured":"World Health organization. Library of AMR national action plans. 2021. Available from: https:\/\/www.who.int\/teams\/surveillance-prevention-control-AMR\/national-action-plan-monitoring-evaluation\/library-of-national-action-plans."},{"key":"878_CR21","unstructured":"World Bank Group. World Bank Country and Lending Groups. 2021. Available from: https:\/\/datahelpdesk.worldbank.org\/knowledgebase\/articles\/906519-world-bank-country-and-lending%20groups#:~:text=For%20the%20current%202021%20fiscalthose%20with%20a%20GNI%20per."},{"key":"878_CR22","volume-title":"Antimicrobial resistance: a manual for developing national action plans, version 1. World health Organization","author":"World Health Organization (WHO), food and agriculture Organization of the United Nations (FAO), world organisation for animal health (OIE)","year":"2016","unstructured":"World Health Organization (WHO), food and agriculture Organization of the United Nations (FAO), world organisation for animal health (OIE). Antimicrobial resistance: a manual for developing national action plans, version 1. World health Organization; 2016."},{"issue":"1","key":"878_CR23","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1186\/s12992-020-00639-3","volume":"16","author":"L Munkholm","year":"2020","unstructured":"Munkholm L, Rubin O. The global governance of antimicrobial resistance: a cross-country study of alignment between the global action plan and national action plans. Glob Health. 2020;16(1):109.","journal-title":"Glob Health"},{"key":"878_CR24","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.12688\/f1000research.20100.1","volume":"8","author":"M Malarski","year":"2019","unstructured":"Malarski M, Hasso-Agopsowicz M, Soble A, Mok W, Mathewson S, Vekemans J. Vaccine impact on antimicrobial resistance to inform Gavi, the vaccine Alliance's 2018 vaccine investment strategy: report from an expert survey. F1000Res. 2019;8:1685.","journal-title":"F1000Res."},{"key":"878_CR25","doi-asserted-by":"crossref","unstructured":"Marchetti F, Prato R, Viale P. Survey among Italian experts on existing vaccines' role in limiting antibiotic resistance. Hum Vaccin Immunother. 2021:1\u20138.","DOI":"10.1080\/21645515.2021.1969853"},{"key":"878_CR26","unstructured":"Food and Agriculture Organization of the United Nations (FAO), World Organisation for Animal Health (OIE), World Health Organization (WHO). Monitoring global progress on antimicrobial resistance: Tripartite AMR country self-assessment survey (TrACSS) 2019-2020. Global analysis report 2021."},{"key":"878_CR27","doi-asserted-by":"crossref","unstructured":"Anderson M, Schulze K, Cassini A, Plauchoras D, Mossialos E. Strengthening implementation of antimicrobial resistance national action plans. Eur J Pub Health. 2020;30(Supplement_5).","DOI":"10.1093\/eurpub\/ckaa165.1200"},{"issue":"9","key":"878_CR28","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.1093\/cid\/ciaa773","volume":"72","author":"R Nieuwlaat","year":"2021","unstructured":"Nieuwlaat R, Mbuagbaw L, Mertz D, Burrows LL, Bowdish DME, Moja L, et al. Coronavirus disease 2019 and antimicrobial resistance: parallel and interacting health emergencies. Clin Infect Dis. 2021;72(9):1657\u20139.","journal-title":"Clin Infect Dis"},{"issue":"8","key":"878_CR29","doi-asserted-by":"publisher","first-page":"Fso736","DOI":"10.2144\/fsoa-2021-0012","volume":"7","author":"RC Founou","year":"2021","unstructured":"Founou RC, Blocker AJ, Noubom M, Tsayem C, Choukem SP, Dongen MV, et al. The COVID-19 pandemic: a threat to antimicrobial resistance containment. Future Sci OA. 2021;7(8):Fso736.","journal-title":"Future Sci OA"},{"key":"878_CR30","unstructured":"WHO. Call to Action on Antimicrobial Resistance 2021. 2021. Available from: https:\/\/www.who.int\/news\/item\/30-07-2021-call-to-action-on-antimicrobial-resistance-2021."},{"key":"878_CR31","unstructured":"WHO. Immunization coverage. 2021. Available from: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/immunization-coverage."}],"updated-by":[{"DOI":"10.1186\/s12992-023-00951-8","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2023,8,8]],"date-time":"2023-08-08T00:00:00Z","timestamp":1691452800000}}],"container-title":["Globalization and Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12992-022-00878-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12992-022-00878-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12992-022-00878-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,9]],"date-time":"2023-08-09T06:03:47Z","timestamp":1691561027000},"score":1,"resource":{"primary":{"URL":"https:\/\/globalizationandhealth.biomedcentral.com\/articles\/10.1186\/s12992-022-00878-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,17]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["878"],"URL":"https:\/\/doi.org\/10.1186\/s12992-022-00878-6","relation":{"correction":[{"id-type":"doi","id":"10.1186\/s12992-023-00951-8","asserted-by":"object"}]},"ISSN":["1744-8603"],"issn-type":[{"value":"1744-8603","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,17]]},"assertion":[{"value":"18 January 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 September 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 October 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 August 2023","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1186\/s12992-023-00951-8","URL":"https:\/\/doi.org\/10.1186\/s12992-023-00951-8","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"LvH, SC and MD declare that they have no competing interests. JP declares that Nivel has received research grants which concern the epidemiology of influenza and vaccination against influenza from WHO, Sanofi Pasteur and the Foundation for Influenza Epidemiology.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"85"}}